A lawsuit filed by New Jersey Attorney General Gurbir S. Grewal against Janssen Pharmaceuticals claims the drugmaker deceptively marketed its opioid products, driving up the cost of health insurance and workers’ compensation coverage for state employers.
Grewal announced the lawsuit against the Johnson & Johnson subsidiary Tuesday. He claimed that Janssen falsely claimed that its Nucynta and Nucynta ER products were safer, milder and less addictive than other opioids, and minimized the risks of opioids generally.
The suit demands that Jassen be “disgorged of i...
Comments